{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:42:06Z","timestamp":1787010126404,"version":"build-2736575974"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>This review aims to explore the relationship between the renin angiotensin system (RAS) and sepsis-associated acute kidney injury (SA-AKI), a common complication in critically ill patients associated with mortality, morbidity, and long-term cardiovascular complications. Additionally, this review aims to identify potential therapeutic approaches to intervene with the RAS and prevent the development of AKI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Recent studies have provided increasing evidence of RAS alteration during sepsis, with systemic and local RAS disturbance, which can contribute to SA-AKI. Angiotensin II was recently approved for catecholamine resistant vasodilatory shock and has been associated with improved outcomes in selected patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>SA-AKI is a common condition that can involve disturbances in the RAS, particularly the canonical angiotensin-converting enzyme (ACE) angiotensin-II (Ang II)\/angiotensin II receptor 1 (AT-1R) axis. Increased renin levels, a key enzyme in the RAS, have been shown to be associated with AKI and may also guide vasopressor therapy in shock. In patients with high renin levels, angiotensin II administration may reduce renin concentration, improve intra-renal hemodynamics, and enhance signaling through the angiotensin II receptor 1. Further studies are needed to explore the role of the RAS in SA-AKI and the potential for targeted therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mcc.0000000000001092","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T08:00:35Z","timestamp":1697788835000},"page":"607-613","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["The role of renin-angiotensin system in sepsis-associated acute kidney injury: mechanisms and therapeutic implications"],"prefix":"10.1097","volume":"29","author":[{"given":"Bruno","family":"Garcia","sequence":"first","affiliation":[{"name":"Department of Anesthesia & Peri-operative Care, Division of Critical Care Medicine, University of California, San Francisco (UCSF), San Francisco, California, USA"},{"name":"Department of Intensive Care, Centre Hospitalier Universitaire de Lille, Lille, France"},{"name":"Experimental Laboratory of Intensive Care, Universit\u00e9 Libre de Bruxelles, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zarbock","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital of M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinaldo","family":"Bellomo","sequence":"additional","affiliation":[{"name":"Department of Intensive Care, Austin Hospital"},{"name":"Australian and New Zealand Intensive Care Research Centre, Monash University"},{"name":"Department of Critical Care, Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Legrand","sequence":"additional","affiliation":[{"name":"Department of Anesthesia & Peri-operative Care, Division of Critical Care Medicine, University of California, San Francisco (UCSF), San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s00134-017-4755-7","article-title":"Acute kidney injury in sepsis","volume":"43","author":"Bellomo","year":"2017","journal-title":"Intensive Care Med"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41581-023-00683-3","article-title":"Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup","volume":"19","author":"Zarbock","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/cc11454","article-title":"Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)","volume":"17","author":"Kellum","year":"2013","journal-title":"Crit Care"},{"issue":"(Suppl)","key":"R5-20250729","doi-asserted-by":"crossref","first-page":"S198","DOI":"10.1097\/CCM.0b013e318168ccd5","article-title":"Pathophysiology of septic acute kidney injury: what do we really know?","volume":"36","author":"Wan","year":"2008","journal-title":"Crit Care Med"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1038\/sj.ki.5000440","article-title":"Renal blood flow in experimental septic acute renal failure","volume":"69","author":"Langenberg","year":"2006","journal-title":"Kidney Int"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1164\/rccm.201511-2285OC","article-title":"Structure and function of the kidney in septic shock. A prospective controlled experimental study","volume":"194","author":"Maiden","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1097\/CCM.0000000000002797","article-title":"Urinary oxygenation as a surrogate measure of medullary oxygenation during Angiotensin II therapy in septic acute kidney injury","volume":"46","author":"Lankadeva","year":"2018","journal-title":"Crit Care Med"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1007\/s00134-011-2267-4","article-title":"The role of renal hypoperfusion in development of renal microcirculatory dysfunction in endotoxemic rats","volume":"37","author":"Legrand","year":"2011","journal-title":"Intensive Care Med"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.kint.2016.07.032","article-title":"Renal perfusion in sepsis: from macro- to microcirculation","volume":"91","author":"Post","year":"2017","journal-title":"Kidney Int"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1097\/CCM.0000000000001198","article-title":"Cortical and medullary tissue perfusion and oxygenation in experimental septic acute kidney injury","volume":"43","author":"Calzavacca","year":"2015","journal-title":"Crit Care Med"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1056\/NEJMra1916393","article-title":"Cardiovascular consequences of acute kidney injury","volume":"382","author":"Legrand","year":"2020","journal-title":"New Engl J Med"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","article-title":"Counter-regulatory renin\u2013angiotensin system in cardiovascular disease","volume":"17","author":"Ocaranza","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccc.2018.11.002","article-title":"Classic and nonclassic renin-angiotensin systems in the critically ill","volume":"35","author":"Bitker","year":"2019","journal-title":"Crit Care Clin"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13054-018-1995-z","article-title":"Angiotensin in critical care","volume":"22","author":"Hall","year":"2018","journal-title":"Crit Care"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13054-018-2202-y","article-title":"Angiotensin converting enzyme defects in shock: implications for future therapy","volume":"22","author":"Chawla","year":"2018","journal-title":"Crit Care"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.HYP.35.1.155","article-title":"Role of the angiotensin Type 2 receptor in the regulation of blood pressure and renal function","volume":"35","author":"Carey","year":"2000","journal-title":"Hypertension"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/HYPERTENSIONAHA.113.01274","article-title":"Angiotensin-(1-7)","volume":"63","author":"Santos","year":"2014","journal-title":"Hypertension"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1681\/ASN.2009070759","article-title":"Macula densa sensing and signaling mechanisms of renin release","volume":"21","author":"Peti-Peterdi","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/CCM.0000000000003544","article-title":"Renin as a marker of tissue-perfusion and prognosis in critically ill patients","volume":"47","author":"Gleeson","year":"2019","journal-title":"Crit Care Med"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1097\/SHK.0000000000001285","article-title":"Plasma renin concentration is associated with hemodynamic deficiency and adverse renal outcome in septic shock","volume":"52","author":"Nguyen","year":"2018","journal-title":"Shock"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13054-021-03725-z","article-title":"Serum renin and major adverse kidney events in critically ill patients: a multicenter prospective study","volume":"25","author":"Flannery","year":"2021","journal-title":"Crit Care"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","article-title":"Renin and survival in patients given Angiotensin II for catecholamine-resistant vasodilatory shock: a clinical trial","volume":"202","author":"Bellomo","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"F487","DOI":"10.1152\/ajprenal.00206.2014","article-title":"A functional (pro)renin receptor is expressed in human lymphocytes and monocytes","volume":"308","author":"Narumi","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13054-020-2733-x","article-title":"Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock","volume":"24","author":"Bellomo","year":"2020","journal-title":"Crit Care"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/CCM.0000000000003092","article-title":"Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II","volume":"46","author":"Tumlin","year":"2018","journal-title":"Crit Care Med"},{"key":"R27-20250729","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13054-023-04446-1","article-title":"Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory posthoc analysis of the ATHOS-3 clinical trial","volume":"27","author":"Wieruszewski","year":"2022","journal-title":"Crit Care"},{"key":"R28-20250729","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/SHK.0000000000002109","article-title":"A pilot study of angiotensin II as primary vasopressor in critically ill adults with vasodilatory hypotension: the ARAMIS study","volume":"59","author":"See","year":"2023","journal-title":"Shock"},{"key":"R29-20250729","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.kint.2020.07.047","article-title":"Impaired angiotensin II type 1 receptor signaling contributes to sepsis induced acute kidney injury","volume":"99","author":"Leisman","year":"2020","journal-title":"Kidney Int"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.34067\/KID.0001562021","article-title":"Expression of ACE2 in the intact and acutely injured kidney","volume":"2","author":"Nath","year":"2021","journal-title":"Kidney360"},{"key":"R31-20250729","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1164\/rccm.202012-4461OC","article-title":"Increased angiotensin-converting enzyme 2 and loss of alveolar type II cells in COVID-19\u2013related acute respiratory distress syndrome","volume":"204","author":"Gerard","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"R32-20250729","doi-asserted-by":"crossref","first-page":"601909","DOI":"10.3389\/fphar.2021.601909","article-title":"Angiotensin (1-7) attenuates sepsis-induced acute kidney injury by regulating the NF-\u03baB pathway","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Pharmacol"},{"key":"R33-20250729","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13054-018-2210-y","article-title":"Angiotensin-(1-7) attenuates organ injury and mortality in rats with polymicrobial sepsis","volume":"22","author":"Tsai","year":"2018","journal-title":"Crit Care"},{"key":"R34-20250729","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13054-023-04396-8","article-title":"Angiotensin 1-7 in an experimental septic shock model","volume":"27","author":"Garcia","year":"2023","journal-title":"Crit Care"},{"key":"R35-20250729","doi-asserted-by":"crossref","first-page":"600163","DOI":"10.3389\/fphar.2021.600163","article-title":"Angiotensin AT2 receptor is anti-inflammatory and reno-protective in lipopolysaccharide mice model: role of IL-10","volume":"12","author":"Fatima","year":"2021","journal-title":"Front Pharmacol"},{"key":"R36-20250729","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1164\/rccm.202010-3873LE","article-title":"Alteration of the renin-angiotensin-aldosterone system in shock: role of the dipeptidyl peptidase 3","volume":"203","author":"Picod","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"R37-20250729","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1111\/j.1742-4658.2011.08275.x","article-title":"Dipeptidyl peptidase III: a multifaceted oligopeptide -end cutter","volume":"278","author":"Prajapati","year":"2011","journal-title":"FEBS J"},{"key":"R38-20250729","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1111\/febs.16429","article-title":"The emerging role of dipeptidyl peptidase 3 in pathophysiology","volume":"290","author":"Malovan","year":"2023","journal-title":"FEBS J"},{"key":"R39-20250729","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1373\/jalm.2018.027995","article-title":"Novel methods for the quantification of dipeptidyl peptidase 3 (DPP3) concentration and activity in human blood samples","volume":"3","author":"Rehfeld","year":"2019","journal-title":"J Appl Laboratory Medicine"},{"key":"R40-20250729","doi-asserted-by":"crossref","first-page":"13711","DOI":"10.1074\/jbc.RA120.014183","article-title":"Dipeptidyl peptidase 3 modulates the renin\u2013angiotensin system in mice","volume":"295","author":"Jha","year":"2020","journal-title":"J Biol Chem"},{"key":"R41-20250729","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13054-021-03471-2","article-title":"Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study","volume":"25","author":"Blet","year":"2021","journal-title":"Crit Care"},{"key":"R42-20250729","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/j.bja.2021.11.021","article-title":"High plasma dipeptidyl peptidase 3 levels are associated with mortality and organ failure in shock: results from the international, prospective and observational FROG-ICU cohort","volume":"128","author":"Deniau","year":"2021","journal-title":"Brit J Anaesth"},{"key":"R43-20250729","doi-asserted-by":"crossref","first-page":"e0238039","DOI":"10.1371\/journal.pone.0238039","article-title":"Inhibition of circulating dipeptidyl-peptidase 3 restores cardiac function in a sepsis-induced model in rats: a proof of concept study","volume":"15","author":"Deniau","year":"2020","journal-title":"PLOS One"},{"key":"R44-20250729","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.kint.2020.06.032","article-title":"A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and death","volume":"99","author":"Ikizler","year":"2021","journal-title":"Kidney Int"},{"key":"R45-20250729","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s00134-018-5160-6","article-title":"Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury","volume":"44","author":"Gayat","year":"2018","journal-title":"Intensive Care Med"},{"key":"R46-20250729","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/CCM.0000000000004641","article-title":"Angiotensin-converting enzyme inhibitors and or receptor blockers after acute kidney injury: rehabilitation of the Supervillains\u2217","volume":"48","author":"Legrand","year":"2020","journal-title":"Crit Care Med"}],"container-title":["Current Opinion in Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000001092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T20:14:59Z","timestamp":1753820099000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000001092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mcc.0000000000001092","relation":{},"ISSN":["1070-5295","1531-7072"],"issn-type":[{"value":"1070-5295","type":"print"},{"value":"1531-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,21]]}}}